InsiderClue
Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Nexalin Technology, Inc.

NXL Clue Score49
United States Fiscal year ends December CIK 0001527352
$3.63 -11.68% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.63 +830.77% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 16 Sep 2022. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Revenue0.1Operating income−6.0Net income−6.1Fiscal year 2022Revenue1.3 +817.2%Operating income−1.8Net income−1.7EPS, diluted−0.30Fiscal year 2023Revenue0.1 −91.6%Operating income−5.7Net income−4.6EPS, diluted−0.63Fiscal year 2024Revenue0.2 +52.3%Operating income−7.8Net income−7.6EPS, diluted−0.83Fiscal year 2025Revenue0.3 +78.8%Operating income−8.4Net income−8.2EPS, diluted−0.50
FY2021FY2022FY2023FY2024FY2025
Revenue 0.1 1.3 0.1 0.2 0.3
Growth +817.2% −91.6% +52.3% +78.8%
Operating income −6.0 −1.8 −5.7 −7.8 −8.4
Net income −6.1 −1.7 −4.6 −7.6 −8.2
Growth
EPS, diluted n/a −0.30 −0.63 −0.83 −0.50

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2021Gross margin85.1%Operating margin−4,177.7%Net margin−4,218.9%Fiscal year 2022Gross margin72.5%Operating margin−138.7%Net margin−128.5%Fiscal year 2023Gross margin76.8%Operating margin−5,143.5%Net margin−4,197.6%Fiscal year 2024Gross margin78.3%Operating margin−4,596.1%Net margin−4,508.7%Fiscal year 2025Gross margin79.7%Operating margin−2,781.7%Net margin−2,725.8%
FY2021FY2022FY2023FY2024FY2025
Gross margin 85.1% 72.5% 76.8% 78.3% 79.7%
Operating margin −4,177.7% −138.7% −5,143.5% −4,596.1% −2,781.7%
Net margin −4,218.9% −128.5% −4,197.6% −4,508.7% −2,725.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flow
Fiscal year 2021Operating cash flow−1.1Fiscal year 2022Operating cash flow−2.2Fiscal year 2023Operating cash flow−3.8Fiscal year 2024Operating cash flow−3.9Fiscal year 2025Operating cash flow−5.0
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −1.1 −2.2 −3.8 −3.9 −5.0

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2021Cash0.7Shareholders’ equity−1.7Fiscal year 2022Cash0.2Shareholders’ equity5.5Fiscal year 2023Cash0.6Shareholders’ equity3.2Fiscal year 2024Cash0.6Shareholders’ equity3.7Fiscal year 2025Cash0.7Shareholders’ equity3.7
FY2021FY2022FY2023FY2024FY2025
Cash 0.7 0.2 0.6 0.6 0.7
Shareholders’ equity −1.7 5.5 3.2 3.7 3.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−1.1 −2.2 −3.8 −3.9 −5.0
Growth
Investment
n/a −6.8 4.5 −0.6 −0.1
Financing
1.7 8.5 −0.2 4.5 5.2

Capital expenditure, dividends and buybacks are shown as money out, so negative.